Conor Kilroy
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
Conor Kilroy is currently Secretary & Chief Legal Officer at Aura Biosciences, Inc., starting in 2025.
Former positions include Secretary & General Counsel at Neurogastrx, Inc. from 2021 to 2023; Secretary, Senior Vice President & General Counsel at Ironwood Pharmaceuticals, Inc. from 2020 to 2021; Counsel at Boston Scientific Corp.
from 2012 to 2013; and Associate at Goodwin Procter LLP from 2007 to 2011.
Education includes undergraduate studies at Brandeis University and graduate studies at Boston College Law School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,37% | 01/07/2026 | 232.693 ( 0,37% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AURA BIOSCIENCES, INC. | Consigliere Generale | 01/04/2024 |
| Società | Posizione | Fine |
|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Consigliere Generale | 01/05/2023 |
| IRONWOOD PHARMACEUTICALS, INC. | Consigliere Generale | 01/02/2021 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/01/2013 |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale